Efficiency of single dose of tolvaptan treatment during the triphasic episode after surgery for craniopharyngioma

10Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Inappropriate antidiuretic hormone syndrome (SIADH) may develop after intracranial surgery. SIADH in the pediatric age group is usually encountered in patients with an intracranial mass both before and after surgery. Fluid restriction is the standard therapy in SIADH. However, a resistant, hyponatremic pattern may be encountered in some cases. Vaptans have been recently introduced for treatment of hyponatremia due to SIADH. There is inadequate data concerning tolvaptan treatment in pediatric patients. We present a 13 year-old female with SIADH of triphasic episode who was transferred to our clinic after surgery for craniopharyngioma. Resistant hyponatremia did not resolve despite fluid restriction and hypertonic saline support. The patient responded rapidly to a single dose of tolvaptan, with no adverse effect, which resulted in successful control of her SIADH.

Cite

CITATION STYLE

APA

Gürbüz, F., Taştan, M., Turan, İ., & Yüksel, B. (2019). Efficiency of single dose of tolvaptan treatment during the triphasic episode after surgery for craniopharyngioma. JCRPE Journal of Clinical Research in Pediatric Endocrinology, 11(2), 202–206. https://doi.org/10.4274/jcrpe.galenos.2018.2018.0182

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free